"Engineering of a Multi-Epitope Subunit Vaccine Against SASRS-CoV-2 Thr" by Aamir Shehzada, Christijogo Sumartono et al.
  •  
  •  
 

Abstract

The COVID-19 outbreak has infected millions of people worldwide, but no vaccine has been discovered to combat it efficiently. This research aims to design a multi-epitope vaccine using highly efficient B- and T-cell epitopes from the SARS-CoV-2 Surabaya isolate through a viroinformatic approach. First, the putative epitopes were linked together to develop tertiary structures and then docked with toll-like receptor 4 (TLR-4) that demonstrated a robust interaction with a low eigenvalue of 4.816138 e-06. Furthermore, the structure's high immunogenic response was observed and successfully cloned into the expression vector pET28a (+). This implies that the designed vaccine can prove effective in combating SARS-CoV-2.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 1
  • Usage
    • Downloads: 291
    • Abstract Views: 214
  • Captures
    • Readers: 7
see details

Share

COinS